side effects of glp 1 drugs risks GLP-1 nausea: How to handle GLP-1s' most common effect GLP-1 Drugs Use, Risks, and Glucagon-like Receptor-1 agonists for obesity:

Cancer cells generate substantial amounts of lactate during aerobic glycolysis, which is expelled into the tumor microenvironment via the monocarboxylate transporter protein (MCT)

The SELECT cardiovascular outcomes trial (N=17,604), published in NEJM 2023 (DOI: 10.1056/NEJMoa2307563), demonstrated a 20% reduction in major adverse cardiovascular events (MACE) -- the composite of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke -- in overweight or obese adults without diabetes

Heres why: Superior Absorption: IV administration bypasses the digestive system, delivering 100% of the glutathione directly into your bloodstream

However, MCAS can set the stage for a host of chronic conditions such as: environmental and food allergies, asthma, autism, autoimmune, eczema, chronic fatigue syndrome, migraines, chronic pain, fibromyalgia, CIRS, GERD, IBS, infertility, insomnia, mood disorders, multiple chemical sensitivities and even POTS (postural orthostatic tachycardia syndrome)

Researchers have tested it in animals for its regenerative effects